NCT01495000 - A Study in Indian Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab | Biotech Hunter

Enrollment

250

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions

Osteoporosis, Postmenopausal

Interventions

DRUG

denosumab

60mg subcutaneous injection, single dose

DRUG

placebo

placebo subcutaneous injection, single dose

Trial Locations (11)

GSK Investigational Site, Delhi

GSK Investigational Site, Ahmedabad

GSK Investigational Site, Vadodra

GSK Investigational Site, Pune

GSK Investigational Site, Nagpur

GSK Investigational Site, Nagpur

GSK Investigational Site, Bangalore

GSK Investigational Site, Bangalore

GSK Investigational Site, Bangalore

GSK Investigational Site, Mangalore

GSK Investigational Site, Trivandrum